ACKR2 and cancer: By integrating pan-cancer data from TCGA, TARGET, and GTEx, the expression patterns of Atypical Chemokine Receptor 2 (ACKR2) across 34 cancers and its correlation with Overall Survival (OS) and Progression-Free Interval (PFI) were analyzed.